Where Will Intercept Pharmaceuticals Be in 5 Years?

Where Will Intercept Pharmaceuticals Be in 5 Years?

Source: 
Motley Fool
snippet: 

Intercept Pharmaceuticals (NASDAQ: ICPT) is in the enviable position of many biotech companies. It boasts a marketed drug on pace to deliver more than $200 million in sales for 2019 and is anticipating an upcoming decision from the Food and Drug Administration that could grant it the first approval for a disease with no approved treatment options.